Marker Therapeutics
(NASDAQ:MRKR)
$3.88
-0.44[-10.19%]
Last update: 6:34PM Get Real Time Here

GET A REPORT ON MRKR SENT RIGHT TO YOUR INBOX

12.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
0
0100

Marker Therapeutics Stock (NASDAQ:MRKR), Quotes and News Summary

Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Open$4.270
Close-
Volume / Avg.132.000 / 26.921K
Day Range4.270 - 4.270
52 Wk Range0.671 - 9.680
Market Cap$34.489M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
61
Short Interest
2.79%
Days to Cover12.03

Recent News

-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell
About Marker Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MRKR
NKGN

FAQ

Q

How do I buy Marker Therapeutics (MRKR) stock?

A

You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Marker Therapeutics's (MRKR) competitors?

Q

What is the target price for Marker Therapeutics (MRKR) stock?

A

The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Roth Capital on Thursday, February 17, 2022. The analyst firm set a price target for 1.00 expecting MRKR to fall to within 12 months (a possible -76.58% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Marker Therapeutics (MRKR)?

A

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $4.27 last updated Today at March 19, 2024 at 9:30 AM EDT.

Q

Does Marker Therapeutics (MRKR) pay a dividend?

A

There are no upcoming dividends for Marker Therapeutics.

Q

When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?

A

Marker Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Marker Therapeutics (MRKR) going to split?

A

There is no upcoming split for Marker Therapeutics.

Q

What sector and industry does Marker Therapeutics (MRKR) operate in?

A

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch